You are here

About the speakers

Register for the E-Alert


We would like to know what challenges you face in treating patients with advanced breast cancer.

Send us your feedback and take this opportunity to submit your questions to our faculty.

Educational need

Clinicians have an unmet need to understand the mechanisms underlying CDK4&6 inhibition, the rationale for using CDK4&6 inhibitors to treat advanced breast cancer, and the clinical data supporting the use of CDK4&6 inhibitors in the treatment of advanced breast cancer.

Made possible by an educational grant from